07:00 , Jun 12, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Dermatology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Dermatology Wounds Leukotriene B4 type 2 receptor (BLT2) Mouse studies suggest BLT2 agonists could help promote wound healing....
07:00 , Mar 29, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Ovarian cancer Leukotriene B4 type 2 receptor (BLT2) In vitro and mouse...
07:00 , Apr 29, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Inflammation

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Inflammation Inflammation Leukotriene B4 (LTB4); leukotriene B4 type 1 receptor (LTB4R; BLT1); leukotriene B4 type 2 receptor (LTB4R2;...